Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
268 studies found for:    "Flavivirus Infections"
Show Display Options
Rank Status Study
1 Completed Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose
Condition: Encephalitis, Japanese
Intervention: Biological: SA-14-14-2 live, attenuated JE vaccine
2 Completed The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon Islands
Conditions: Flavivirus Infection;   Alphavirus Infections;   Malaria;   Parasitic Disease;   Leptospirosis;   Hypertension;   Metabolic Syndromes
Intervention: Other: diagnosis, treatment and education
3 Enrolling by invitation A Zika Virus DNA Vaccine in Healthy Adults and Adolescents
Conditions: Zika Virus;   Zika Virus Infection;   Virus Diseases;   Flavivirus Infections;   Flaviviral Diseases;   Flaviviridae Infections;   RNA Virus Infections
Interventions: Biological: VRC-ZKADNA090-00-VP;   Other: VRC-PBSPLA043-00-VP
4 Recruiting Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area
Condition: Zika Virus Infection
Interventions: Other: Placebo;   Biological: Zika Virus Purified Inactivated Vaccine (ZPIV)
5 Recruiting A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.
Condition: Zika Virus Infection
Interventions: Biological: IXIARO;   Biological: YF Vax 17D Strain;   Biological: Zika Virus Purified Inactivated Vaccine (ZPIV)
6 Recruiting ZIKA Vaccine in Naive Subjects
Condition: Zika Virus Infection
Interventions: Drug: Saline;   Biological: Zika Virus Purified Inactivated Vaccine (ZPIV)
7 Recruiting Zika Virus Infection's Neonatal and Pediatric Consequences in French Department of America
Condition: Zika Virus Infection on Fetus and Child During the Pregnancy
Interventions: Other: fundus examination;   Other: Head ultrasound
8 Recruiting Persistence of Zika Virus in Semen After Acute Infection
Conditions: Zika Virus;   Zika Virus Disease;   Virus Shedding;   Transmission
9 Completed Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers
Conditions: Dengue;   Dengue Hemorrhagic Fever;   Yellow Fever
Interventions: Biological: Live, attenuated dengue serotype 1, 2, 3, and 4 virus;   Biological: Yellow fever vaccine;   Biological: Measles, mumps, and rubella vaccine;   Biological: Pneumococcal Conjugated Vaccine;   Biological: Hepatitis A Pediatric Vaccine;   Biological: Diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae vaccine;   Biological: Yellow Fever Vaccine;   Biological: Placebo (NaCl)
10 Completed Pilot Survey of Dengue Fever in Solomon Islands
Condition: Arbovirus Infections
11 Completed A Study of Balapiravir in Patients With Dengue Virus Infection
Condition: Dengue
Interventions: Drug: balapiravir [RO4588161];   Drug: placebo
12 Not yet recruiting Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil
Condition: Zika Virus
Intervention: Diagnostic Test: RT-PCR
13 Recruiting Zika-Vaccine Dose Finding Study Regarding Safety, Immunogenicity and Tolerability
Condition: Zika Virus
Interventions: Biological: MV-ZIKA;   Other: Placebo
14 Recruiting Understanding Excretion and Infectivity of Zika Virus in Semen During and After Infection
Condition: Zika Virus
Intervention: Other: Semen analysis and semen PCR for Zika virus
15 Recruiting Zika in Infants and Pregnancy (ZIP)
Condition: Zika Virus Disease (Disorder)
16 Completed Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers
Conditions: Dengue;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus;   Biological: DTaP IPV//Hib vaccine;   Biological: Placebo;   Biological: Measles, mumps, and rubella vaccine;   Biological: Pneumococcal vaccine
17 Completed
Has Results
Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America
Conditions: Dengue;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotype 1 , 2, 3 , and 4 virus;   Biological: NaCl 0.9%;   Biological: Tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccine adsorbed;   Biological: Meningococcal A+C vaccine
18 Completed Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus
Condition: Dengue Hemorrhagic Fever
Interventions: Biological: rDEN1delta30;   Biological: rDEN2/4delta30(ME);   Biological: Placebo to rDEN1delta30 or rDEN2/4delta30(ME)
19 Recruiting Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)
Conditions: Zika Virus;   Dengue Virus;   Chikungunya Virus Infections
20 Withdrawn TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant
Condition: Dengue
Interventions: Biological: TDENV-PIV;   Biological: TDENV-F17;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.